You are here

ENERGESIS PHARMACEUTICALS INC

Company Information
Address
770 BOYLSTON ST APT 26G
BOSTON, MA 02199-7723
United States


http://www.energesispharma.com

Information

UEI: JA9AEU5KN7R1

# of Employees: 4


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. In Vivo Proof of Concept and Target Identification Using Small Molecule Stimulators of Brown Adipogenesis

    Amount: $1,988,528.00

    PROJECT SUMMARY/ABSTRACT Obesity has reached epidemic proportions in the U.S. and plays a major role in the development of type 2 diabetes, dyslipidemia, and cardiovascular disease. There remains a ve ...

    SBIRPhase II2021Department of Health and Human Services National Institutes of Health
  2. Development of Novel Brown Adipocyte Recruiters for the Treatment of Obesity

    Amount: $295,420.00

    PROJECT SUMMARY/ABSTRACT Obesity has reached epidemic proportions in the U.S. and plays a major role in the development of type 2 diabetes, dyslipidemia, and cardiovascular disease. There remains a ve ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  3. Optimization and Pre-Clinical Studies of a Protein Therapeutic for Recruiting Brown Adipocytes

    Amount: $1,775,542.00

    Obesity has reached epidemic proportions in the US and plays a major role in the development of typediabetes and cardiovascular diseaseThere remains a very significant need for better treatmentsWhile ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  4. Establishing In Vivo Proof of Concept of Brown Adipogenesis Using Approved Drugs

    Amount: $1,781,519.00

    DESCRIPTION provided by applicant Obesity has reached epidemic proportions in the U S and plays a major role in the development of type diabetes dyslipidemia and cardiovascular disease There ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  5. Pre-Clinical Optimization of Human Brown Adipocyte Cell Therapy

    Amount: $998,628.00

    Presently available pharmacotherapy for diabetes and pre-diabetes can be effective initially, but the natural history of these conditions typically features deterioration of blood sugar control over t ...

    SBIRPhase II2015Department of Defense Defense Health Agency
  6. Target Identification of Proteins and Peptides Capable of Recruitment of Brown Ad

    Amount: $276,203.00

    DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the U.S. and plays a major role in the development of type 2 diabetes, dyslipidemia, and cardiovascular disease. While ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  7. Radioactive Stents for Brachytherapy of Esophageal Cancers

    Amount: $168,876.00

    DESCRIPTION (provided by applicant): Obesity has reached epidemic proportions in the U.S. and plays a major role in the development of type 2 diabetes, dyslipidemia, and cardiovascular disease. There ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  8. Human Brown Adipocyte Transplantation and In Vivo Metabolic Characterization

    Amount: $749,692.00

    Obesity and its associated metabolic complications including diabetes are becoming increasingly prevalent in the general population as well as in military personnel. Brown adipose tissue (BAT) is a ma ...

    STTRPhase II2012Department of Defense Army
  9. Cell Culture Approaches to Generating Brown Adipose Tissue for Autologous Transplantation

    Amount: $98,942.00

    Obesity and its associated metabolic complications including diabetes are becoming increasingly prevalent in the general population as well as in military personnel. Brown adipose tissue (BAT) is a ma ...

    STTRPhase I2011Department of Defense Army
US Flag An Official Website of the United States Government